AVIR Cash & Short-Term Investments

Atea Pharmaceuticals Inc · Cash & Short-Term Investments

AVIR logo

AVIR Cash & Short-Term Investments

Latest reported$301.83M
AVIR FY Cash & Short-Term Investments ($34.49M → $301.83M)
High-resolution chart · PNG

AVIR cash & short-term investments history

Annual fiscal periods · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Atea Pharmaceuticals Inc Cash & Short-Term Investments — Annual fiscal periods (USD)
Period endingCash & Short-Term Investments (USD)
301,830,000
454,721,000
578,106,000
646,709,000
764,375,000
850,117,000
21,661,000
34,492,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.